Close

Celgene Corp (CELG) Tops Q3 EPS by 2c; Bumps Guidance Higher

October 25, 2012 7:34 AM EDT
Celgene Corp (NASDAQ: CELG) reported Q3 EPS of $1.29, $0.02 better than the analyst estimate of $1.27. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.41 billion.

Celgene Corp sees FY2012 EPS of $4.85-4.90, versus prior guidance of $4.80-4.85 and the consensus of $4.88. Celgene Corp sees FY2012 revenue of $5.45-5.55 billion, versus prior guidance of $5.4-5.6 billion and the consensus of $5.5 billion.

For earnings history and earnings-related data on Celgene Corp (CELG) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities

Earnings